venetoclax
roche,abbvie
['venetoclax']
a very important point that i really liked from $apto data presented at #eha2023 the combo tus/ven cri achieved in 1st cycle treatment &amp; only 15-days from a patient who had previously been refractory to chemotherapy &amp; hma/ven (hypomethylating agent + venetoclax)
more at esh
Equity market consultant. Technical Analysis Trader with over 25 years of experience. #Biotech Deep dive research.
 Biotech Trading Analyst @ChimeraResearch